Aviron Message Board - Msg: 13422309

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.250

+0.3%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Finley who wrote (570)	4/14/2000 3:01:00 AM
From: kinetic	Read Replies (1) of 645

Might get a boost this morning. From Business Weeks's April 24 issue: BUSINESSWEEK INVESTOR Smart Biotech Buys The volatile market has made these stocks look cheap--at least for investors with long time horizons. FDA STOCK COMPANY/SYMBOL PRODUCT APPROVAL PRICE* AVIRON AVIR FluMist Expected $26.50 Mountain View, Calif. for flu 2001 CELGENE CELG Thalomide Approved 92.20 Warren, N.J. for cancer CEPHALON CEPH Provigil for Approved 40.80 West Chester, Pa. sleep disorders ILEX ONCOLOGY ILXO Campath Expected 35.10 San Antonio for cancer summer 2000 QLT PHOTOTHER. QLTI Visudyne Expected 58.50 Vancouver, B.C. for macular spring 2000 degeneration 52-WEEK % OFF COMPANY/SYMBOL HIGHS 52-WEEK HIGH AVIRON AVIR $54.40 -54% Mountain View, Calif. CELGENE CELG 187.00 -54% Warren, N.J. CEPHALON CEPH 74.40 -47% West Chester, Pa. ILEX ONCOLOGY ILXO 54.10 -41% San Antonio QLT PHOTOTHER. QLTI 85.75 -34% Vancouver, B.C. *As of April 7

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next